Abstract
The binding of Graves’ immunoglobulins to membranes of human eye muscle (HEM) and guinea pig Harderian gland (HG) were studied. The membrane fraction of 100,000 × g sediment was used for ELISA. Serum samples from 55 patients with Graves’ ophthalmopathy were evaluated for binding to the membrane preparation. There was a higher binding to HG with the sera from the patients with Graves’ ophthalmopathy than in the control group (p < 0.01), but there was no difference in binding to HEM. Purification of IgG from sera improved binding to HG in both patients’ (p< 0.001) and control group (p < 0.005). There was also an increase in percentage of positive responses obtained with IgG 48% vs serum samples 37%. In 23 out of 24 patients we found the thickening of extraocular muscles by A-scan ultrasonography. In these groups of patients and 3 others with malignant ophthalmopathy the binding of IgG preparation to HG was similar to control group. In all assays there was an overlap between patients with Graves’ ophthalmopathy and control subjects, and a lack of relationship between the responses in ELISA and clinical or severity of ophthalmopathy.
Similar content being viewed by others
References
Kriss J.P., Konishi J., Herman M. Studies of the pathogenesis of Graves’ ophthalmopathy (with some related observations regarding therapy). Recent Prog. Horm. Res. 3: 533, 1975.
Lewis M., Topliss D.J., Okita N., How J., Row V.V., Volpe R. The etiology of endocrine exophthalmos. In: Franklin E. (Ed.), Clinical immunology update. Elsevier Biomedical, New York, 1983, p. 261.
Jacobson D.H., Gorman C.A. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis and treatment. Endocr. Rev. 5: 200, 1984.
Wall J.R. Autoimmunity and Graves’ ophthalmopathy. In: Gorman C.A., Waller R.R., Dyer J.A. (Eds.), The eye and orbit in thyroid disease. Raven Press, New York, 1984, p. 103.
Kodoma K., Sikorska H., Bandy-Dafor P., Bayly R., Wall J.R. Demonstration of the circulating autoantibody against a soluble eye-muscle antigen in Graves’ ophthalmopathy. Lancet 2: 1353, 1982.
Kendall-Taylor P., Atkinson S., Holcombe M. A specific IgG in Graves’ ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity. Br. Med. J. 288: 1183, 1984.
Atkinson S., Holcombe, M., Kendall-Taylor P. Ophthalmopathic immunoglobulin in patients with Graves’ ophthalmopathy. Lancet 2: 374, 1984.
Atkinson S., Holcombe M., Kendall-Taylor P. An antibody to eye muscle in Graves’ ophthalmopathy. In: Volpe R., Wall J.R., Walfish P.G. (Eds.), Autoimmunity and the thyroid. Academic Press, Orlando, 1985, p. 333
Faryna M., Nauman J., Gardas A. Measurement of autoantibodies against human eye muscle plasma membranes in Graves’ opthalmopathy. Br. Med. J. 290: 191, 1985.
Kadlubowski M., Irvine W.J., Rowland A.C. The lack of specificity of ophthalmic immunoglobulins in Graves’ disease. J. Clin. Endocrinol. Metab. 63: 990, 1986.
Ahmann A., Baker J.R. Jr., Weetman A.O., Wartofsky L., Nutman T.B., Burman K.D. Antibodies to porcine eye muscle in patients with Graves’ ophthalmopathy: Identification of serum immunoglobulins directed against unique determinations by immunobloting and enzyme-link immunosorbent assay. J. Clin. Endocrinol. Metab. 64: 454, 1987.
Werner S.C. Modification of the classification of the eye changes of Graves’ disease. Recommendations of the Ad Hoc Committee of the American thyroid association. J. Clin. Endocrinol. Metab. 44: 203, 1977.
Windell C.C. Cytochemical localization of 5’nucleotidase in sub-cellular fractions isolated from rat liver. J. Cell Biol. 52: 542, 1972.
Chen P.S., Toribara T.Y., Warner H. Micrbdetermination of phosphorus. Anal. Chem. 28: 1756, 1956.
McKenzie J.M., Zakarija M; Assays of thyroid-stimulating antibody. In: Birnbaumer L., O’Malley B.W. (Eds.), Methods in Enzymology. Academic Press, New York, 1985, vol. 109, p. 677.
Schonheyder H., Andersen P. Effect of bovine serum albumin on antibody determination by the enzyme-linked immunoadsorbent assay. J. Immunol. Methods 72: 251, 1984.
Henderson L.F., Henderson N.D. A dictionary of scientific terms. Oliver C. Boyd Pub. Co., Edinburgh, 1953, p. 187.
Smelser G.K. Experimental production of exophthalmos resembling that found in Graves’ disease. Proc. Soc. Exp. Biol. Med. 35: 128, 1936.
Ludwig A.W., Boag N.F., Soffer L.J. Role of mucopolysaccharides in pathogenesis of experimental exophthalmos. Proc. Soc. Exp. Biol. Med. 73: 137, 1956.
Winand R.J., Kohn L.D. Retrobulbar modifications in experimental exophthalmos: The effect of thyrotropin and an exophthalmos-producing substance derived from thyrotropin on the 35-S incorporation and glycosaminoglycan content of Harderian glands. Endocrinology 93: 670, 1973.
Pisarev M.A., Altschuler N., Davison T.A. Immune exophthalamos due to Harderian gland antigen. Endocrinology 83: 903, 1969.
Singh S.P., McKenzie J.M. The influence of thyrotropin on Harderian gland glycosaminoglycans of the mouse. Proc. Soc. Exp. Biol. Med. 135: 478, 1970.
Sikorska H., Miller A., Wall J.R. Analysis of nonspecific reaction to enzyme linked immunosorbent assay testing for human eye muscle specific antibodies in Graves’ ophthalmopathy and Hashimoto’s thyroiditis. In: Volpe R. (Ed.), Autoimmunity and the thyroid. Academic Press, 1985, p. 335.
Miller A., Sikorska H., Salvi M., Wall J.R. Evaluation of an enzyme-linked immunosorbent assay for the measurement of autoantibodies against eye muscle membrane antigens in Graves’ ophthalmopathy. Acta Endocrinol. (Kbh.) 113: 514, 1986.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Banovac, K., Levis, S. & Byrne, S.F. A study of the binding of Graves’ immunoglobulins to orbital antigens. J Endocrinol Invest 11, 483–488 (1988). https://doi.org/10.1007/BF03350165
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350165